D Wave Quantum Inc vs Tilray Brands Inc — how do they compare? D Wave Quantum Inc trades at $14.57 (market cap $5.54B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: D Wave Quantum Inc is far larger — about 10.4× Tilray Brands Inc's market cap, and D Wave Quantum Inc is more actively traded (16,671,452 versus 9,099,075). Which is the better fit depends on your goals — on Pluang, investors hold D Wave Quantum Inc for 32 Days and Tilray Brands Inc for 31 Days on average.
| QBTS | TLRY | |
|---|---|---|
Market Cap | $5.54B | $530.54M |
Volume | 16,671,452 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $44.78 | $21.00 |
52-Week Low | $12.98 | $3.57 |
Typical Hold Time | 32 Days | 31 Days |
Enterprise Value | $5.04B | $684.46M |
Signals from Pluang's Aura AI — not financial advice
D-Wave Quantum (QBTS) trades at $14.60, down 4.07% with a bearish technical signal despite unanimous analyst buy ratings and a $34.38 consensus target. The quantum computing company shows concerning fundamentals with a P/S ratio of 421.36 and negative profitability metrics, including a -2,001.59% net income margin. Recent quarterly earnings have been mixed, missing expectations in Q4 2025 and Q2 2026 while beating in Q1 2026.
While analyst optimism remains high with 100% buy ratings, significant financial risks persist including ongoing losses, negative cash flow projections for 2026, and multiple fraud investigations. The stock faces substantial execution risk in the competitive quantum computing space, though long-term potential exists if the company can achieve commercial scalability and positive cash flow generation.
Tilray Brands (TLRY) trades at $3.59, down 3.36% on the day and near 52-week lows, with bearish technical indicators dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings have consistently missed expectations, though analyst consensus remains cautiously optimistic with a $65.01 price target. The stock faces significant headwinds from ongoing profitability challenges and cannabis industry volatility.
TLRY presents a high-risk opportunity with potential upside if management can achieve profitability and capitalize on cannabis reform catalysts. However, persistent losses, negative cash flow, and competitive pressures create substantial downside risk. Investors should weigh the speculative nature against potential regulatory catalysts in the coming months.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →